1. Bacon PA. The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med. 2005. 352:330–332.
2. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993. 33:4–9.
3. Mickle JP, McLennan JE, Lidden CW. Cortical vein thrombosis in Wegener's granulomatosis. Case report. J Neurosurg. 1977. 46:248–251.
4. von Scheven E, Lu TT, Emery HM, Elder ME, Wara DW. Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability. Arthritis Rheum. 2003. 49:862–865.
5. Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L. Central nervous system involvement in Wegener's granulomatosis. Medicine (Baltimore). 2006. 85:54–65.
6. de Groot K, Schmidt DK, Arlt AC, Gross WL, Reinhold-Keller E. Standardized neurologic evaluations of 128 patients with Wegener's granulomatosis. Arch Neurol. 2001. 58:1215–1221.
7. Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, et al. WGET Research Group. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum. 2005. 52:2168–2178.
8. Ha YJ, Lee KH, Jung SY, Park HS, Lee SK, Park YB. A case of Wegener's granulomatosis presenting with cerebral infarction and intracerebral hemorrhage. J Korean Rheum Assoc. 2010. 17:283–288.